AgomAb Therapeutics NV has set terms for its initial public offering, positioning the fibrosis-focus...
The IPO market delivered a wide range of outcomes in today’s triple-header, reinforcing how selectiv...
Eikon Therapeutics has filed for an initial public offering, seeking to list its common stock on the...